Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

recruiting125%
completed375%

Recent Activity

1 active trials
Showing 4 of 4
completed

Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients

NCT07200583
recruitingnot_applicable

Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder

NCT06763848
completednot_applicable

A Clinical Study of Immunoadsorption Therapy for Dilated Cardiomyopathy

NCT02915718
completednot_applicable

Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy

NCT00558584

Clinical Trials (4)

Showing 4 of 4 trials
NCT07200583

Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients

Completed
NCT06763848Not Applicable

Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder

Recruiting
NCT02915718Not Applicable

A Clinical Study of Immunoadsorption Therapy for Dilated Cardiomyopathy

Completed
NCT00558584Not Applicable

Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4